|
|
||||||||
Laboratorio de Neurobiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago 1, Chile
| |
ABSTRACT |
|---|
|
|
|---|
We studied the effects of nitric oxide (NO) released by NO
donors on cat carotid body (CB) chemosensory activity during normoxia and hypoxia. CBs excised from pentobarbital
sodium-anaesthetized cats were perfused with Tyrode at 38°C
and pH 7.40. The frequency of chemosensory discharges
(
x) was recorded from the carotid sinus nerve, and
changes of NO concentration were measured by a chronoamperometric
technique, with NO-selective carbon-fiber microelectrodes inserted in
the CB. During steady chemosensory excitation induced by hypoxia, bolus
injections of NO (
NO = 0.5-12 µM), released by
S-nitroso-N-acetylpenicillamine (SNAP) and
6-(2-hydroxy-1-methyl-nitrosohydrazino)-N-methyl-1-hexanamine (NOC-9), transiently reduced
x in a dose-dependent
manner. However, during normoxia, the same concentration of NO
(
NO = 0.5-13 µM) released by the NO donors increased
x in a dose-dependent manner. The present results show a
dual effect of NO on CB chemoreception that is dependent on the
PO2 levels. During hypoxia, NO is predominantly an inhibitor of chemoreception, whereas, in normoxia, NO increased
x. The mechanisms by which NO produces chemosensory
excitation during normoxia remain to be determined.
dual effect; hypoxia; oxygen
| |
INTRODUCTION |
|---|
|
|
|---|
IT HAS BEEN PROPOSED
THAT nitric oxide (NO) gas produced within the carotid body (CB)
is an inhibitory modulator of hypoxic chemoreception (8, 28, 31,
34). Indeed, in the cat CB perfused in vitro, the administration
of L-arginine (34), NO donors such as sodium
nitroprusside (8) and nitroglycerine (34),
and 25 ppm NO gas (18) reduces the amplitude of the chemosensory response to hypoxia. On the other hand, the NO synthase (NOS) inhibitor
N
-nitro-L-arginine methyl ester
(L-NAME) enhances the hypoxic response in the cat CB in
situ (17) and in vitro (34). Furthermore, the
inhibition of NOS increases basal chemosensory discharges in the cat CB
in situ (17) and in vitro (8, 20, 28, 34). Sodium nitroprusside (SNP) reverses this excitatory effect in the cat
CB perfused in vitro (8) but not in situ
(17).
Recently, our laboratory studied the effects of SNP (1-2
mg/kg iv) on the carotid chemosensory responses to sodium cyanide (NaCN), dopamine, and hyperoxia in paralyzed and artificially ventilated cats (17). Unexpectedly, we found that SNP
increased basal chemosensory discharges, although reducing both the
NaCN-induced chemosensory excitation over baseline and the transient
chemosensory inhibition induced by dopamine. Contrary to what is seen
in the in situ preparation, our laboratory (2) and others
(8, 35) have found that SNP reduced or had no effect on
basal frequency of chemosensory discharge (
x) in the cat
CB preparations superfused or perfused in vitro with saline solutions.
A major difference between in vitro and in situ CB preparations is the
presence of large amounts of endothelium and vascular smooth muscle
tissue in the whole cat, which is needed to activate SNP for releasing NO (22). Thus it is likely that the large amounts of NO
released from SNP in situ may account for the increased basal
chemosensory activity. Indeed, it is well known that NO may impair the
electron transport chain and oxidative phosphorylation (4,
6), conditions that are expected to increase chemosensory
discharge (5, 25, 26). Accordingly, we would expect that
high concentrations of NO should increase chemosensory discharge.
To test this hypothesis, we studied the effects of NO released by NO
donors on CB chemosensory activity during normoxia and hypoxia. Because
we are aware that SNP is a potential releaser of cyanide ions
(15), two different spontaneous NO donors,
6-(2-hydroxy-1-methyl-nitrosohydrazino)-N-methyl-1-hexanamine (NOC-9) and S-nitroso-N-acetylpenicillamine
(SNAP) were used. This study was performed using a perfused cat CB,
preparation in vitro that allowed fast delivery of the stimuli through
the CB vessels and simultaneous recording of CB chemosensory discharge and chronoamperometric measurements of NO with carbon microelectrodes.
| |
METHODS |
|---|
|
|
|---|
Experiments were performed on 10 CBs excised from seven adult
cats. The cats were anesthetized with pentobarbital sodium (40 mg/kg
ip), followed by additional doses (12 mg iv) to maintain a level of
surgical anesthesia. The carotid bifurcation including the CB and the
carotid sinus nerve (CSN) was perfused with Tyrode solution as
previously described (19). Briefly, the carotid bifurcation was cannulated through the common carotid artery, excised
from the cat, and placed in a chamber. Each CB was perfused by gravity
with Tyrode at pH 7.40, equilibrated with 20% O2 and 5%
CO2, and simultaneously superfused with Tyrode equilibrated with 95% N2 and 5% CO2. The composition of
the Tyrode was, in mM, 154.0 Na+, 4.7 K+, 2.2 Ca2+, 1.1 Mg2+, 123.0 Cl
, 21.0 glutamate, 21.3 HCO3
, 5.5 D-glucose, and 5.0 HEPES. The temperature of the fluid in the chamber was maintained at 38.0 ± 0.5°C with a regulated
heating system. Chemosensory discharges were recorded from the CSN,
which was placed on a pair of platinum electrodes and lifted into
mineral oil. The neural signals were preamplified and amplified,
filtered (10 Hz-1 kHz, notch filter 50 Hz), and fed to an electronic
amplitude discriminator that allowed the selection of action potentials of a given amplitude above the baseline noise. The selected
chemosensory impulses were counted with a frequency meter to measure
x expressed in Hz. The
x signal was
digitized with an analog-digital board (DIGITADA 1200A, Axon
Instruments) for later analyses.
NO was measured through a computerized chronoamperometric system (IVEC
10, Medical System). NO-sensitive electrodes consisting of single
carbon fibers (30-µm diameter) covered with porphyrin and Nafion
(Quanteon) were gently inserted into the CB. A potential of 0.9 V, with
respect to the reference Ag-AgCl electrode, was applied for 100 ms at a
rate of 5 Hz. The resulting oxidation current was digitally integrated
during the last 80 ms of each pulse, averaged for five cycles,
displayed at a rate of 1 Hz, and stored in the computer. The electrodes
were calibrated with SNAP (100-600 µM) in Tyrode solution at pH
7.40 (see Ref. 33 for a similar method). Only carbon microelectrodes
showing high sensitivity and linear currents
(r2 > 0.95) were used. Using an
independent technique for measuring NO, based on a gas-phase
chemiluminescent reaction between NO and ozone, with a NO analyzer
(Sievers 280, Sievers Instruments), we found that SNAP produced NO in a
molar ratio of 1 to 0.01 in Tyrode solution (100 µM SNAP produces 1 µM NO). The integrated oxidation current was expressed as changes of
NO concentration over baseline levels (
NO).
SNAP (18-1,800 µg) and NOC-9 (20-900 µg) were dissolved
in Tyrode and injected into the perfusate line in boluses of
0.2-0.5 ml during normoxic
(PO2
125 Torr) or hypoxic
(PO2
30 Torr) perfusion of the CBs.
Results were expressed as means ± SE. Statistical differences for
multiple-dependents samples and for multiple samples were assessed with
Kruskal-Wallis test, followed by paired comparisons through Conover
test (30).
| |
RESULTS |
|---|
|
|
|---|
CB levels of NO during hypoxia.
Figure 1 shows the effects of hypoxic
stimulation on the NO-electrochemical signal and chemosensory
discharges in two CBs. Hypoxia promptly increased
x to a
maximal level, which showed a slight adaptation to a steady level. In
all CBs, hypoxic perfusion increased
x from a baseline
of 56.2 ± 12 Hz to a steady value of 334.7 ± 32.5 Hz
(P < 0.01). The most common NO-electrochemical response observed in 9 out of 10 CBs is shown in Fig. 1A.
Hypoxia produced a transient reduction of the NO-electrochemical signal that was followed by a recovery to the previous baseline value. However, hypoxia induced a late increase of the electrochemical signal
after 10 min of hypoxia in only one CB (Fig. 1B). The time course of this late increase in the electrochemical signal resembles the delayed efflux of dopamine previously measured in the cat CB
(17). Although porphyrin carbon fiber microelectrodes are more selective to NO than to dopamine (1 > 100), a high
concentration of dopamine could be detected. This interpretation is
supported by the fact that the amplitude of this electrochemical signal was reduced by repeated hypoxic stimuli, as happens with dopamine (16).
|
Effects of NO on carotid chemosensory activity during normoxia.
Figure 2 shows the excitatory effects of
increasing concentrations of NO produced by injections of 20, 40, and
200 µg NOC-9 and 1,800 µg SNAP on carotid chemosensory
discharges during normoxic perfusion
(PO2
125 Torr). Note that the
x peak preceded the corresponding NO peak by
~15-20 s. The inflexion of the NO signal after the injection of
NOC-9 was due to the lower temperature of the NOC-9 solutions (room
temperature vs. 38.5°C). Although the amplitude of the maximal
x responses induced by 40 and 200 µg NOC-9 were
similar, the chemosensory response induced by 200 µg NOC-9 showed a
secondary response. In this case, the chemosensory response induced by
SNAP also consisted of two phases. An initial and rapid increase in
x, followed by a slow secondary response. This biphasic
response resembles the chemosensory response to large doses of NaCN
(50-100 µg). When we repeated the injections of NOC-9 or SNAP at
intervals as short as 2 min, we observed some degree of desensitization
to the excitatory effects of NO.
|
x
during normoxia in six CBs are summarized in Fig.
3. The response to 180 µg SNAP was not
significantly different from the control baseline, because, in most
preparations, the dose of 180 µg did not increase NO. To study the
correlation between the maximal concentrations of NO produced by
injections of the NO donors and the maximal change in chemosensory
activity (
x = maximum
x
basal
x), we fitted the data from five CBs to a linear
regression (Fig. 4). The coefficient of
regression for the linear fit was 0.73 (P < 0.05),
indicating that the correlation was positive and significant. Thus
higher levels of NO produced larger chemosensory excitations.
|
|
x
during normoxia was induced by NO, we studied the effect of the NO
scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-a-oxyl-3-oxide (PTIO) (37) on the excitatory chemosensory response elicited by
SNAP. Figure 5 compares the effect of one
injection of 450 µg SNAP and two injections of the same dose of SNAP
that was previously mixed with 100 µg PTIO for 5 min. As expected,
the chemosensory response induced by SNAP was reduced by PTIO.
Unfortunately, we were unable to record the NO changes, because PTIO
per se produced a large oxidation current and prevented the recording
of NO.
|
Effects of NO on carotid chemosensory activity during hypoxia.
Figure 6 compares the effects of three
doses of NOC-9 on two CBs during steady chemosensory excitation induced
by hypoxia (PO2
30 Torr). Hypoxia
increased
x to a steady level, whereas NO released by
NOC-9 transiently reduced the increased
x in a dose-dependent manner. The doses of 40 and 200 µg NOC-9 that
increased NO to ~1 and 6 µM, respectively, reduced, but did not
entirely abolish, the chemosensory excitation induced by hypoxia (Fig. 6A). However, a large dose of NOC-9 (400 µg), which
increased NO up to 11 µM, entirely abolished the hypoxia-induced
chemosensory excitation (Fig. 6B). When low doses of NOC-9
were injected during hypoxia, chemosensory activity returned to the
previous baseline values on withdrawal of the hypoxic perfusion (Fig.
6A). However, after the application of large doses of NOC-9
(400-800 µg) during hypoxia, the chemosensory activity presented
large excitatory rebound, as is shown in Fig. 6B. This
rebound was observed in all CBs, even when they were perfused with
normoxic Tyrode solution. Note that the 200-µg dose of NOC-9
initially produced a brief chemosensory excitation, which was then
followed by a more marked inhibition (Fig. 6A). This dual
effect of NO on
x during hypoxia was commonly observed,
but its magnitude was variable. Figure 7
shows the clear dual effect of NO on
x during hypoxia.
Almost the same level of NO produced by 1,800 µg SNAP caused
chemosensory excitation during normoxia. However, during hypoxia, NO
produced a dual effect consisting of an initial but brief chemosensory excitation followed by a more marked inhibition of chemosensory activity.
|
|
x (
x = minimum
x
steady
x) attained during
steady chemosensory excitation induced by hypoxia in five CBs. In this
case, the correlation (r = 0.87, P < 0.05) was negative and significant, indicating that large NO amounts
produced chemosensory inhibition in a dose-dependent manner during
hypoxia.
|
x, although they
increased NO up to 8 and 6 µM, respectively.
|
Effects of several doses of NO on CB oxygen sensing.
In six preparations, we tested the effects of repeated large doses of
NO donors. After several injections of large doses of NO donors during
normoxia, we observed a spontaneous increase in basal chemosensory
discharges, up to maximal discharge, in three of the CB preparations.
This spontaneous increase of basal discharges was reversed by hyperoxic
perfusion. Figure 10 shows an
example in which, after eight large doses of SNAP (900 and 1,800 µg)
applied during normoxia, basal
x spontaneously increased up to 400 Hz. The increased
x returned to baseline only
when the CB was perfused with Tyrode equilibrated with hyperoxia (95% O2 and 5% CO2). Switching back from hyperoxia
to hypoxia or normoxia resulted in an increase of
x to
maximal discharge. Note that during hyperoxic or normoxic perfusion,
SNAP did not further increase
x (Fig. 10B).
These results suggest that oxygen sensing was affected by large NO
concentrations.
|
| |
DISCUSSION |
|---|
|
|
|---|
According to the current hypothesis of chemoreception, the glomus
cells of the CB are the primary sites of transduction of the hypoxic
stimulus. In response to hypoxia, glomus cells are expected to release
one (or more) excitatory transmitter(s) that in turn increases the
frequency of discharges in nerve terminals of chemosensory petrosal
neurons (13). In addition to the excitatory transmitter(s), other molecules produced within the CB may act as
chemical modulator(s) of the chemosensory process. It has been proposed
that endogenous NO is a tonic inhibitor of carotid chemoreception to
hypoxia (8, 20, 27, 35). This proposition is based on the
immunocytochemical localization of NOS in autonomic and petrosal
sensory fibers (14, 28, 34, 35) and on the use of
pharmacological tools, i.e., NO donors and NOS inhibitors (8, 20,
28, 34). The present results agree and extend previous observations that administration of NO donors such as nitroglycerine and SNP (8, 34) to the cat CB perfused in vitro reduces
the chemosensory response to hypoxia, indicating that NO is
predominantly an inhibitor during hypoxia. In addition, we found, in
the present study, that large doses of NO donors abolished the
chemosensory excitation induced by hypoxia. This observation suggests a
crucial role for NO on hypoxic chemoreception. However, we do not know if the complete inhibition of NO on
x is a physiological
or pharmacological effect because the level of NO in the CB is unknown.
Our results cannot rule out that the inhibition of chemosensory
excitation during hypoxia induced by NO was, in part, due to a
vasodilatation (23, 34, 35). Recently, Lahiri and Buerk
(23), using a similar in vitro perfused preparation of the
cat CB, found that SNP infusion increases CB tissue
PO2 and reduces basal discharges, supporting
the idea that part of the inhibitory effect of NO on CB chemoreception
is secondary to vascular changes. However, it is not clear how a
vasodilatation may totally explain the inhibition of the increased
x during perfusion and superfusion of the CB with
hypoxic media (PO2
30 Torr). In addition to
vascular-dependent mechanisms, the glomus cells and petrosal neurons
are other sites for the inhibitory actions of NO. Indeed, Summers et
al. (29) found that NO donors such as SNP and spermine
inhibit L-type Ca2+ currents in rabbit glomus
cell through a cGMP-independent mechanism, which is mediated by a
direct modification of the thiol groups of the calcium channel
proteins. On the other hand, we found that SNP and L-NAME
modulate the acetylcholine-induced activity in isolated petrosal
ganglion neurons that selectively project through the carotid sinus
nerve (3). SNP reduced the sensitivity and amplitude of
dose-dependent increases of carotid sinus nerve frequency of discharge
induced by acetylcholine, whereas L-NAME slightly enhanced
the response (1). In the isolated petrosal ganglion, the
superfusion with a low concentration of SNP did not change the basal
frequency of carotid sinus nerve discharge; however, we did not study
the effect of other NO donors (1).
In addition to the chemosensory inhibition produced by NO during
hypoxia, our results show that the same concentrations of NO produced
chemosensory excitation after normoxic perfusion. Furthermore, after
several large doses of SNAP or NOC-9, basal
x increased
spontaneously up to the maximal discharge in one-half of the CBs
studied. Similar to what we found in situ, the increased basal
x returned to normal baseline levels only when the CB
was perfused with hyperoxia, suggesting that the oxygen sensing
mechanisms of the chemoreceptor cells were impaired. The transient
chemosensory excitation produced by bolus injections of NO donors seems
to be mediated by NO, because the selective NO scavenger PTIO reduced the excitatory response elicited by SNAP. The mechanisms underlying the
transient and prolonged excitatory effects of NO on chemosensory discharges during normoxia remain to be identified. However, the most
possible targets for the action of NO are the soluble guanylyl cyclase
and the cytochrome oxidase, because these enzymes are highly sensitive
to NO in the nM and µM range (4, 9). As it was mentioned
above, a vasodilator effect of NO produced by the activation of
guanylyl cyclase in smooth muscle is expected to reduce chemosensory
discharge (23, 35), but an impairment of cytochrome
oxidase redox activity is expected to increase chemosensory discharges
(5, 25, 26). In recent years, the effects of NO on the
respiratory chain and oxidative phosphorylation have received great
attention. It is well known that NO inhibits mitochondrial respiration
at different levels, reducing oxygen consumption. Indeed, NO at low
concentrations (50 nM-5 µM) specifically and reversibly inhibits
cytochrome oxidase (complex IV) in competition with O2
(4). Nevertheless, at higher concentrations (>5 µM) NO
also inhibits other complexes of the respiratory chain in isolated rat
heart mitochondria (6). Several mechanisms, such as
nitrosylation, oxidization of protein thiols, and removal of iron from
iron-sulphur centers have been proposed to explain the effects of NO on
the respiratory chain (4). Thus it is likely that the
concentrations of NO released by NO donors in our experiments
(0.5-13 µM) may impair the electron transport chain and
oxidative phosphorylation in the mitochondria of the glomus cells.
However, at high levels, NO may also interact with other nonrespiratory
molecules such as free radicals, oxygen, superoxide anion, and iron and
thiol groups in protein. Some of these reactions result in the
oxidation of NO to nitrite and nitrate, which terminates its effect,
but the products of other potential reactions may modify protein
structure and function. Consequently, we cannot rule out any effects of large amounts of NO on glomus cell intracellular calcium and
neurotransmitter release.
Another possible mediator for the NO effects is its metabolite peroxinitrite. NO reacts with the superoxide anion to form peroxinitrite on a molar basis. Peroxynitrite is a potent oxidant and nitrating agent, which may react with the amino acid tyrosine in cellular proteins, converting it to nitrosotyrosine. Nitration may in turn affect protein function. Recent studies have shown that peroxinitrite formation mediates prolonged vasoconstrictor in cerebral (10) and cardiac vascular territories after hypoxia-reoxygenation (38). Because we used a perfused preparation of the CB, it is possible that peroxinitrite, acting as a vasoconstrictor, may have counteracted the vasodilator effect of NO and mediated the excitatory effects of NO donors on CB chemoreception in normoxia. However, the vasoconstrictor effect of peroxynitrite occurred at concentrations >25 µM, whereas vasodilatation prevailed at lower concentrations (10). This value exceeded the maximal NO level released by the donors in this study (NO = 13 µM). In addition, peroxinitrite acts as a potent vasodilator in other vascular territories (7, 32); however, it may impair vascular relaxation, which can be prevented by coinfusion with SNAP (32). High concentrations of peroxinitrite can also produce inhibition of mitochondrial complexes I, II, and IV, damage to the mitochondrial membrane, mitochondrial swelling, depolarization, and calcium release (4, 6).
It has been proposed that CB chemosensory excitation induced by hypoxia may be the result of a decreased availability of an inhibitory chemical messenger such as NO (27). Given the fact that inhibition of NOS activity increases basal chemosensory discharges and NOS activity is reduced at low PO2 related to normoxic controls (28), it is likely that at low concentrations of endogenous NO may exert a tonic inhibitory effect on chemosensory discharges during normoxia. Thus it is possible that the increased chemosensory activity induced by hypoxia resulted from reduced production of NO. Our results did not support this hypothesis because they showed that NO production did change or was only initially reduced during hypoxia and then remained constant during 2-5 min of hypoxic stimulation. The method used in the present study did not allow for measuring of the actual NO levels in the CB, because the NO oxidation current was expressed as changes of NO concentration over baseline. The basal level of NO in the CB remains unknown. However, the physiological tissue concentration of NO ranged between 20 nM-1 µM (21). From the above discussion, it is clear that NO may influence oxygen sensing in the CB by several mechanisms. However, a novel possibility is that the ratio NO/O2 may be crucial to regulating the respiratory rate, playing a physiological role in oxygen sensing. Moreover, the recent finding that the mitochondria produce significant amounts of NO to regulate their own respiration (11, 12) suggests that NO may be important for the physiological regulation of energy metabolism. It is possible that the NO inhibition of cytochrome oxidase may be involved in the physiological regulation of respiratory rate (11, 12); however, there is no definitive evidence showing that NO regulation of mitochondrial respiration occurs in situ, and the interpretation is complicated because NO may also affect tissue respiration by cGMP-dependent mechanisms (4). The dual effects of NO on chemoreception observed herein resemble the effects of carbon monoxide (CO) on cat CB chemoreception to hypoxia (24). At low concentrations, CO inhibits hypoxic chemoreception, presumably by binding to a membrane CO-binding pigment, which is not the cytochrome oxidase a3. At high concentrations, CO produces chemosensory excitation, which is fully reversed by bright light (21). Wilson et al. (36) found that the photochemical action spectrum showed a 432:590 nm ratio of ~6, which is characteristic of the CO complex of mitochondrial cytochrome oxidase.
In summary, our results show that NO induced a dual effect on carotid chemosensory discharges depending on the PO2 level. At low PO2, NO is predominantly an inhibitor of the increased chemosensory discharges, whereas, at normoxia, NO increases chemosensory discharges. During hypoxic stimulation in some CBs, we also observed a dual effect consisting in a rapid excitation followed by a more prolonged inhibition. The inhibitory effect of NO is compatible with its known action on CB blood vessels (23, 34), glomus cells (29, 34), and petrosal neuron activity (1). The mechanism underlying the excitatory effect on chemosensory discharges is unknown, but it seems to be related with the oxygen sensing mechanism of the chemoreceptor cells (5).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Carolina Larraín for assistance in the preparation of the experiments and the manuscript.
| |
FOOTNOTES |
|---|
This work was supported by National Fund for Scientific and Technological Development of Chile Grant 198-0965.
Address for reprint requests and other correspondence: R. Iturriaga, Laboratorio de Neurobiología, Facultad de Ciencias Biológicas, P. Universidad Católica of Chile, Casilla 114-D, Santiago 1, Chile (E-mail: riturria{at}genes.bio.puc.cl).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 4 February 2000; accepted in final form 2 May 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Alcayaga, J,
Barrios M,
Bustos F,
Miranda G,
Molina V,
and
Iturriaga R.
Modulatory effect of nitric oxide on acetylcholine-induced activation of cat petrosal ganglion neurons in vitro.
Brain Res
825:
194-198,
1999[ISI][Medline].
2.
Alcayaga, J,
Iturriaga R,
Ramirez J,
Readi R,
Quezada C,
and
Salinas S.
Cat carotid body chemosensory response to nonhypoxic stimuli is inhibited by sodium nitroprusside both in situ and in vitro.
Brain Res
767:
384-387,
1997[ISI][Medline].
3.
Alcayaga, J,
Iturriaga R,
Varas R,
Arroyo J,
and
Zapata P.
Selective activation of carotid nerve fibers by acetylcholine applied to the cat petrosal ganglion in vitro.
Brain Res
786:
47-54,
1998[ISI][Medline].
4.
Brown, CG.
Nitric oxide and mitochondrial respiration.
Biochem Biophys Acta
1411:
351-369,
1999[Medline].
5.
Buerk, DG,
Iturriaga R,
and
Lahiri S.
Testing the metabolic hypothesis of O2 chemoreception in the cat carotid body in vitro.
J Appl Physiol
76:
1317-1339,
1994
6.
Cassina, A,
and
Radi R.
Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.
Arch Biochem Biophys
328:
309-316,
1996[ISI][Medline].
7.
Chabot, F,
Mitchell JA,
Quinlan GJ,
and
Evans TW.
Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: Role of poly(adenosine 5'-diphosphoribose) synthase.
Br J Pharmacol
121:
485-490,
1997[ISI][Medline].
8.
Chugh, DK,
Katayama M,
Mokashi A,
Debout DE,
Ray DK,
and
Lahiri S.
Nitric oxide-related inhibition of carotid chemosensory activity in the cat.
Respir Physiol
97:
147-152,
1994[ISI][Medline].
9.
Clementi, E,
Brown GC,
Foxwell N,
and
Moncada S.
On the mechanism by which vascular endothelial cells regulate their oxygen consumption.
Proc Natl Acad Sci USA
96:
1559-1562,
1999
10.
Elliott, SJ,
Lacey DJ,
Chilian WM,
and
Brezezinska AK.
Peroxynitrite is a contractile agonist of cerebral artery smooth muscle.
Am J Physiol Heart Circ Physiol
275:
H1585-H1591,
1998
11.
Ghafourifar, P,
and
Richter C.
Nitric oxide synthase activity in mitochondria.
FEBS Lett
418:
291-296,
1997[ISI][Medline].
12.
Giulivi, C.
Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism.
Biochem J
332:
673-679,
1998.
13.
González, C,
Almaraz L,
Obeso A,
and
Rigual R.
Carotid body chemoreceptors: from natural stimuli to sensory discharges.
Physiol Rev
74:
829-898,
1994
14.
Grimes, PA,
Lahiri S,
Stone R,
Mokashi A,
and
Chugh D.
Nitric oxide synthase occurs in neurons and nerve fibers of the carotid body.
Adv Exp Med Biol
360:
221-224,
1994[Medline].
15.
Ikeda, S,
Schweiss JF,
Frank PA,
and
Homan SM.
In vitro cyanide release from sodium nitroprusside.
Anesthesiology
66:
381-385,
1987[ISI][Medline].
16.
Iturriaga, R,
and
Alcayaga J.
Effects of CO2-HCO3
on catecholamine efflux from the cat carotid body.
J Appl Physiol
84:
60-68,
1998
17.
Iturriaga, R,
Alcayaga J,
and
Rey S.
Sodium nitroprusside blocks the cat carotid chemosensory inhibition induced by dopamine, but not that by hyperoxia.
Brain Res
799:
26-34,
1998[ISI][Medline].
18.
Iturriaga, R,
Mosqueira M,
and
Villanueva S.
Effects of nitric oxide gas on carotid body chemosensory response to hypoxia.
Brain Res
855:
282-286,
2000[ISI][Medline].
19.
Iturriaga, R,
Rumsey WL,
Mokashi A,
Spergel D,
Wilson DF,
and
Lahiri S.
In vitro perfused-superfused cat carotid body for physiological and pharmacological studies.
J Appl Physiol
70:
1393-1400,
1991
20.
Katayama, M,
Chugh DK,
Mokashi A,
Ray DK,
Bebout DE,
and
Lahiri S.
NO mimics O2 in the carotid body chemoreception.
Adv Exp Med Biol
360:
225-227,
1994[Medline].
21.
Kelm, M.
Nitric oxide metabolism and breakdown.
Biochim Biophys Acta
1411:
273-289,
1999[Medline].
22.
Kowaluk, E,
Seth E,
and
Fung H.
Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle.
J Pharmacol Exp Ther
262:
916-922,
1992
23.
Lahiri, S,
and
Buerk D.
Vascular and metabolic effects of nitric oxide synthase inhibition evaluated by tissue PO2 measurements in carotid body.
In: Oxygen Transport to Tissue XX, edited by Hudetz AG,
and Bruley DF.. New York: Plenum, 1998, p. 455-460.
24.
Lahiri, S,
Iturriaga R,
Mokashi A,
Ray DK,
and
Chugh D.
CO reveals dual mechanisms of O2 chemoreception in the cat carotid body.
Respir Physiol
94:
227-240,
1993[ISI][Medline].
25.
Mulligan, E,
and
Lahiri S.
Separation of carotid body chemoreceptor responses to O2 and CO2 by oligomycin and by actinomycin A.
Am J Physiol Cell Physiol
242:
C200-C206,
1982
26.
Mulligan, E,
Lahiri S,
and
Storey BT.
Carotid body O2 chemoreception and mitochondrial oxidative phosphorylation.
J Appl Physiol
51:
438-466,
1981
27.
Prabhakar, NR.
NO and CO as second messengers in oxygen sensing in the carotid body.
Respir Physiol
115:
161-168,
1999[ISI][Medline].
28.
Prabhakar, NR,
Kumar GK,
Chang CH,
Agani FH,
and
Haxhiu MA.
Nitric oxide in the sensory function of the carotid body.
Brain Res
625:
16-22,
1993[ISI][Medline].
29.
Summers, BA,
Overholt JL,
and
Prabhakar NR.
Nitric oxide inhibits L-type Ca2+ current in glomus cells of the rabbit carotid body via a cGMP-independent mechanism.
J Neurophysiol
81:
1449-1457,
1999
30.
Theodorson-Norheim, E.
Kruskal-Wallis test: basic computer program to perform nonparametric one-way analysis of variance and multiple comparisons of ranks of several independent samples.
Comput Methods Programs Biomed
23:
57-62,
1986[ISI][Medline].
31.
Trzebski, A,
Sato Y,
Susuki A,
and
Sato A.
Inhibition of nitric oxide synthesis potentiates the responsiveness of carotid chemoreceptors to systemic hypoxia in the rat.
Neurosci Lett
190:
29-33,
1995[ISI][Medline].
32.
Villa, LM,
Salas E,
Darley-Usmar VM,
Radomski MW,
and
Moncada S.
Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart.
Proc Natl Acad Sci USA
91:
12383-12387,
1994
33.
Wada, K,
Kamisaki Y,
Ohkura T,
Kanda G,
Nakamoto K,
Kishimoto Y,
Ashida K,
and
Itho T.
Direct measurement of nitric oxide release in gastric mucosa during ischemia-reperfusion in rats.
Am J Physiol Gastrointest Liver Physiol
274:
G465-G471,
1998
34.
Wang, Z-Z,
Stensaas LJ,
Bredt DS,
Dinger BG,
and
Fidone SJ.
Localization and actions of nitric oxide in the cat carotid body.
Neuroscience
60:
275-286,
1994[ISI][Medline].
35.
Wang, Z-Z,
Stensaas LJ,
Dinger BG,
and
Fidone SJ.
Nitric oxide mediates chemoreceptor inhibition in the cat carotid body.
Neuroscience
65:
217-229,
1995[ISI][Medline].
36.
Wilson, DF,
Mokashi A,
Chugh D,
Vinogradov S,
Osanai S,
and
Lahiri S.
The primary oxygen sensor of the cat carotid body is cytochrome a3 of the mitochondrial respiratory chain.
FEBS Lett
351:
370-374,
1994[ISI][Medline].
37.
Yoshida, M,
Akaike T,
Wada Y,
Sato KK,
Ikeda K,
Ueda S,
and
Maeda H.
Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity.
Biochem Biophys Res Commun
202:
923-930,
1994[ISI][Medline].
38.
Zou, M-H,
and
Bachschmid M.
Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostaciclyn synthesis.
J Exp Med
190:
135-139,
1999
This article has been cited by other articles:
![]() |
L. He, J. Chen, X. Liu, B. Dinger, and S. Fidone Enhanced nitric oxide-mediated chemoreceptor inhibition and altered cyclic GMP signaling in rat carotid body following chronic hypoxia Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1463 - L1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Weiss, M. D. Y. Liu, and J. Huang Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension Exp Physiol, January 1, 2007; 92(1): 21 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Li, Y.-F. Li, D. Liu, K. G. Cornish, K. P. Patel, I. H. Zucker, K. M. Channon, and H. D. Schultz Gene Transfer of Neuronal Nitric Oxide Synthase to Carotid Body Reverses Enhanced Chemoreceptor Function in Heart Failure Rabbits Circ. Res., August 5, 2005; 97(3): 260 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Li, S.-Y. Sun, J. L. Overholt, N. R. Prabhakar, G. J. Rozanski, I. H. Zucker, and H. D. Schultz Attenuated outward potassium currents in carotid body glomus cells of heart failure rabbit: involvement of nitric oxide J. Physiol., February 15, 2004; 555(1): 219 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Valdes, M. Mosqueira, S. Rey, R. Del Rio, and R. Iturriaga Inhibitory effects of NO on carotid body: contribution of neural and endothelial nitric oxide synthase isoforms Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L57 - L68. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |